Embolism – Diagnostics – Overview of Information and Clinical Research

Embolism happens when something blocks a blood vessel inside your body. Most often, a blood clot breaks free from another location—like a vein in your leg—and travels through your bloodstream until it gets stuck. When this blockage prevents blood from reaching organs and tissues that need oxygen, it can cause serious health problems or even become life-threatening.

Introduction: Who Should Undergo Diagnostics

If you experience sudden shortness of breath, chest pain that worsens when you breathe deeply, or a rapid heartbeat, you should seek medical attention immediately. These symptoms might signal an embolism, which is a blockage in a blood vessel caused by something traveling through your bloodstream. The most common warning signs can appear suddenly or develop over several days or weeks, and many people initially mistake them for other conditions like a heart attack.^[1]

Anyone experiencing these symptoms should undergo diagnostic testing without delay, especially if they have risk factors for blood clots. People who have recently had surgery, been inactive for long periods, or have certain medical conditions are at higher risk. If you notice swelling, pain, warmth, or redness in one of your legs, this could indicate a deep vein thrombosis (DVT), which is a blood clot in a deep vein that can break off and travel to your lungs, causing a pulmonary embolism.^[3]

Seeking diagnostics is particularly important because embolism symptoms can be vague and overlap with many other health problems. Some people have mild symptoms that appear slowly, while others develop severe symptoms within minutes or even seconds after the blockage occurs. Prompt diagnosis makes the difference between successful treatment and serious complications, including organ damage or death. About one-third of people with pulmonary embolism die before receiving proper diagnosis and treatment, which highlights why recognizing symptoms early and getting tested quickly is so critical.^[9]

⚠️ Important

If you or someone near you shows signs of trouble breathing, chest pain, or coughs up blood, call emergency services immediately. Embolism is a medical emergency that requires urgent care. Do not wait to see if symptoms improve on their own, as delays in treatment can be fatal.

Diagnostic Methods for Identifying Embolism

Diagnosing an embolism can be challenging because symptoms often mimic other heart and lung conditions. Doctors use a combination of clinical assessments, blood tests, and imaging studies to confirm whether a blockage exists and determine its location and severity.^[8]

Clinical Probability Scoring Systems

When you arrive at a medical facility with symptoms suggesting an embolism, doctors first assess how likely it is that you actually have one. They use standardized scoring systems called the Wells criteria and Geneva score to evaluate your risk based on your symptoms, medical history, and risk factors. These tools help doctors decide which diagnostic tests to order next and how urgently you need them.^[4]

The Wells criteria consider factors like whether you have signs of deep vein thrombosis, whether your heart rate is elevated, whether you have been immobile recently, and whether you have had previous blood clots. The Geneva score uses similar information but weighs the factors slightly differently. Both systems help doctors avoid unnecessary testing in low-risk patients while ensuring that high-risk patients receive immediate imaging and other diagnostics.^[11]

Blood Tests

One of the first diagnostic tests doctors order is a blood test measuring D-dimer levels. D-dimer is a substance that forms when blood clots break down in your body. High D-dimer levels suggest that blood clots may be present somewhere, although many other conditions can also cause elevated D-dimer, which means this test alone cannot confirm an embolism. A normal D-dimer result, however, can help rule out an embolism in patients with low clinical probability.^[8]

Doctors also measure oxygen and carbon dioxide levels in your blood through a test called arterial blood gas analysis. When a blood clot blocks vessels in your lungs, oxygen levels typically drop and carbon dioxide levels may rise. Additional blood tests check your clotting factors to see if you have an inherited or acquired condition that makes your blood clot too easily.^[8]

Imaging Tests

Imaging tests provide the most definitive evidence of an embolism by showing the actual blockage in your blood vessels. The most common and accurate imaging method for diagnosing pulmonary embolism is CT pulmonary angiography, which uses X-rays and a special dye injected into your veins to create detailed cross-sectional images of your lungs. This test can show exactly where clots are located and how large they are, helping doctors plan treatment.^[8]

For patients who cannot undergo CT scanning—perhaps because they are allergic to the contrast dye or have kidney problems—doctors may use a different test called a ventilation-perfusion scan (V-Q scan). This test involves inhaling a small amount of radioactive gas and having a radioactive substance injected into your veins. Special cameras then take pictures showing how air and blood flow through your lungs. Areas where air reaches but blood does not suggest a blockage.^[8]

Chest X-rays are often performed early in the evaluation, although they cannot diagnose embolism directly. They help rule out other conditions that might cause similar symptoms, such as pneumonia or collapsed lung. X-rays may appear completely normal even when a significant embolism is present, which is why additional testing is usually necessary.^[8]

Ultrasound Examination

Since most pulmonary embolisms originate from blood clots in the legs, doctors often perform an ultrasound of your leg veins called duplex ultrasonography or compression ultrasonography. This painless test uses sound waves to create images of blood flow in your deep veins. A technician moves a wand-shaped device over your skin, and the resulting images show whether clots are present in the thigh, knee, calf, or sometimes arm veins.^[8]

Finding a clot in a leg vein confirms the need for immediate treatment, even if lung imaging has not yet been completed. If no clots are found in the legs and your symptoms suggest pulmonary embolism, doctors focus on directly imaging the lungs to look for blockages there.^[8]

Heart Imaging

An echocardiogram uses sound waves to create moving images of your heart. This test helps doctors see if a pulmonary embolism is putting strain on the right side of your heart, which pumps blood into your lungs. When large clots block blood flow to the lungs, the right side of the heart must work harder and may show signs of damage or failure. This information helps doctors determine how serious the embolism is and how aggressively to treat it.^[8]

In patients who are critically ill and cannot be moved to the radiology department, doctors may perform bedside ultrasound of the heart to quickly assess right heart strain. This rapid assessment can guide immediate treatment decisions when every minute counts.^[4]

Additional Diagnostic Considerations

The specific diagnostic approach varies based on how stable you are when you arrive for care. Patients with normal blood pressure and stable vital signs typically undergo the standard sequence of clinical assessment, D-dimer testing, and CT pulmonary angiography. However, patients with dangerously low blood pressure, severe shortness of breath, or signs of shock need immediate bedside imaging and may proceed directly to urgent treatment without completing all diagnostic tests first.^[4]

For diagnosing embolisms in locations other than the lungs—such as in brain arteries, which can cause stroke—doctors use different imaging methods. Brain embolisms are typically diagnosed with CT scans or MRI of the brain, sometimes combined with angiography to visualize the blood vessels. Embolisms in the legs, kidneys, or other organs may require targeted ultrasound or CT angiography of those specific areas.^[1]

Diagnostics for Clinical Trial Qualification

When researchers study new treatments for embolism in clinical trials, they use very specific diagnostic criteria to ensure all participants truly have the condition being studied. These qualification standards are more rigorous than routine clinical diagnosis because research results depend on having a clearly defined patient group.^[4]

Most clinical trials for pulmonary embolism require participants to have the diagnosis confirmed by CT pulmonary angiography showing definite blood clots in the lung arteries. Some trials also accept V-Q scan results showing high probability of embolism, but CT confirmation is generally preferred because it provides more precise information about clot location and size. The diagnostic imaging must typically be performed within a specific time window, often within 24 to 48 hours before enrollment, to ensure participants have acute rather than chronic or resolved embolisms.^[11]

Clinical trials often stratify participants based on embolism severity, which requires additional diagnostic testing beyond simply confirming the presence of clots. Researchers assess whether patients have evidence of right heart strain on echocardiogram or elevated levels of certain blood markers like troponin or brain natriuretic peptide (BNP), which indicate heart muscle stress or damage. These measurements help classify embolisms as low-risk, intermediate-risk, or high-risk, and some trials enroll only patients in specific risk categories.^[4]

To participate in trials testing new anticoagulant medications, patients typically need blood tests measuring kidney function and liver function, as these organs process blood-thinning drugs. Trials may exclude people whose test results fall outside certain ranges, since abnormal kidney or liver function can affect how medications work or increase bleeding risks. Baseline measurements of blood cell counts, especially platelet counts, are also standard qualification criteria.^[11]

Some clinical trials require documentation of the suspected origin of the embolism. For example, trials specifically studying embolisms caused by deep vein thrombosis may require ultrasound evidence of leg vein clots as an entry criterion. Trials examining prevention of recurrent embolisms often require documentation of at least one previous episode through medical records showing prior diagnostic imaging results.^[4]

The diagnostic workup for trial qualification may include testing for inherited or acquired blood clotting disorders, especially in trials studying long-term anticoagulation or examining why some people develop recurrent embolisms. Blood tests can identify genetic mutations like Factor V Leiden or prothrombin gene mutation, as well as acquired conditions like antiphospholipid syndrome. However, many trials deliberately exclude patients with these conditions to focus on more typical cases.^[20]

⚠️ Important

Clinical trial diagnostic requirements are much stricter than those used in routine medical care. Just because your doctor diagnosed you with embolism does not automatically mean you qualify for a research study. Each trial has its own specific diagnostic criteria, and you may need to undergo additional testing to determine eligibility.

Clinical trials also establish detailed exclusion criteria based on diagnostic findings. Patients with certain imaging findings—such as chronic blood clots rather than fresh ones, or clots combined with other lung diseases—may be excluded because these factors could confuse study results. Similarly, people with very mild embolisms visible only on imaging but causing no symptoms might be excluded from trials testing treatments for acute symptomatic disease.^[4]

The diagnostic standards used in clinical trials help ensure that research findings are reliable and can be applied to future patients with similar confirmed diagnoses. These rigorous qualification criteria, while necessary for good research, mean that trial results may not perfectly represent all real-world patients, particularly those with unusual presentations or multiple coexisting conditions.^[11]

Prognosis and Survival Rate

Prognosis

The outlook for people diagnosed with embolism varies greatly depending on the size and location of the blockage, how quickly treatment begins, and whether underlying health conditions exist. When caught early and treated promptly, most people survive and recover well. However, embolism remains a serious condition with potentially severe consequences.^[9]

For pulmonary embolism specifically, the prognosis depends heavily on whether the clot causes strain on the right side of the heart. Small clots that do not affect heart function generally have an excellent prognosis with proper anticoagulation treatment. Medium-sized clots causing some heart strain carry intermediate risk, while large clots causing severe heart dysfunction or low blood pressure represent medical emergencies with much poorer outcomes if not treated aggressively.^[4]

Some people experience long-term complications after recovering from embolism. Around 30 percent of patients who have deep vein thrombosis in their legs develop post-thrombotic syndrome, which causes chronic leg swelling, pain, and skin changes. A small percentage of pulmonary embolism survivors develop chronic thromboembolic pulmonary hypertension (CTEPH), a condition where persistent blockages or scar tissue in lung vessels cause ongoing breathing problems and heart strain.^[20]

People who have had one embolism face increased risk of having another. The chance of recurrence depends on what caused the first clot. If the embolism resulted from a temporary situation like surgery or injury, the risk of another clot is relatively low once the temporary risk factor resolves. However, if the cause remains unknown or involves ongoing risk factors like cancer or inherited clotting disorders, the risk of recurrence stays elevated. For patients with unprovoked embolism who complete three to six months of blood thinner treatment, the risk of another clot within the next year is about 10 to 15 percent, and within five years, the risk is approximately 5 percent.^[1]

Long-term anticoagulation treatment significantly reduces recurrence risk but carries its own risks, particularly bleeding complications. Doctors carefully balance these risks when deciding how long to continue blood thinner therapy. Some patients need lifelong anticoagulation, while others can safely stop treatment after several months.^[20]

Survival Rate

Pulmonary embolism is the third leading cause of death from cardiovascular disease worldwide, after heart attack and stroke. Without prompt diagnosis and treatment, about 33 percent of people with pulmonary embolism die before receiving proper care. This high early mortality rate emphasizes why recognizing symptoms and seeking immediate medical attention is critical.^[9]

With timely treatment, survival rates improve dramatically. The specific survival rate depends on the severity of the embolism at presentation. Patients with small embolisms who remain stable, with normal blood pressure and no signs of heart strain, have survival rates exceeding 95 percent with appropriate anticoagulation therapy. Those with intermediate-risk embolisms showing some heart strain on testing but maintaining stable blood pressure have slightly lower survival rates, typically in the 85 to 95 percent range.^[4]

High-risk patients presenting with severely low blood pressure or shock have much poorer outcomes. Even with aggressive treatment including clot-dissolving medications or surgical removal of clots, mortality rates for these critically ill patients can reach 30 to 50 percent. The presence of cardiac arrest at presentation carries particularly grim prognosis.^[4]

About 900,000 people receive a diagnosis of venous thromboembolism in the United States each year. Pulmonary embolism contributes to a significant portion of these cases and remains a major cause of preventable hospital deaths.^[1]

Recovery time varies among survivors. Most people can expect several weeks to several months before returning to normal activities. During recovery, continued treatment with blood thinners is essential. Many patients experience gradual improvement in breathing and exercise tolerance over time, although some persistent symptoms may remain in those who develop chronic complications.^[16]

#1 Clinical Trials Search in Europe

Embolism – Diagnostics

Introduction: Who Should Undergo Diagnostics